11 Pages Posted: 24 Dec 2011
Date Written: December 1, 2011
This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
Keywords: Intellectual property rights, international price discrimination, TRIPS agreement, pharmaceutical industry, markups
JEL Classification: D4, F13, L1, L65, O34
Suggested Citation: Suggested Citation
Hellerstein, Rebecca, What Do Drug Monopolies Cost Consumers in Developing Countries? (December 1, 2011). FRB of New York Staff Report No. 530. Available at SSRN: https://ssrn.com/abstract=1976372 or http://dx.doi.org/10.2139/ssrn.1976372